Opportunity Information: Apply for PAR 16 224
Apply for PAR 16 224
- The HHS-NIH11 in the education, health sector is offering a public funding opportunity titled "NIDA Research Education Program for Clinical Researchers and Clinicians (R25)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279,.
- This funding opportunity was created on May 05, 2016 and posted on May 05, 2016.
- Applicants must submit their applications by Sep 07, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $350,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIDA Research Education Program for Clinical Researchers and Clinicians (R25), funding opportunity number PAR-16-224, is a National Institutes of Health (NIH) research education grant designed to build and strengthen the workforce needed to address the United States' biomedical, behavioral, and clinical research priorities, with a specific emphasis on substance use and addiction. Run through the Department of Health and Human Services (HHS) and NIH (listed as HHS-NIH11), the program uses the R25 mechanism to support structured education activities that expand the research knowledge and capabilities of people in clinically focused careers, including current or future clinicians, service providers, and clinical researchers. A key point is that the program is aimed at research education tied to substance abuse and addiction science, not general clinical training, and it cannot be used to pay for clinical instruction that is unrelated to research.
The overall purpose of the opportunity is to complement and enhance existing training pathways by creating additional, targeted learning experiences that help clinicians and clinician-researchers become more effective consumers and producers of addiction-related research. In practical terms, the intent is to develop people who can bridge the worlds of patient care and research by improving their ability to understand research methods, engage with evidence-based practices, and contribute to studies that advance prevention, diagnosis, treatment, and service delivery for substance use disorders. The program explicitly encourages designs that help participants build research-relevant skills and exposure while remaining grounded in real clinical and service settings.
To meet that goal, the announcement highlights two main types of supported activities: Courses for Skills Development and Research Experiences. Courses for Skills Development generally refers to organized instruction that strengthens research competencies, such as study design, clinical trial methods, ethical and regulatory issues, data analysis, implementation or dissemination approaches, and other tools that clinicians and clinical researchers need to participate meaningfully in addiction research. Research Experiences are meant to provide hands-on engagement in research environments, allowing participants to learn by doing, often through mentored projects, participation in ongoing studies, or structured research practicums that align with substance use and addiction topics. The emphasis on creativity signals that applicants can propose program models that fit their target audience, as long as the primary focus remains on these research education elements.
Eligibility is broad and includes many kinds of domestic organizations that can deliver high-quality research education programming. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and certain tribal organizations; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding institutions of higher education where noted); for-profit organizations other than small businesses; small businesses; and other entities as allowed under the additional eligibility language in the full announcement. The funding activity category is listed under Education and Health, and the CFDA number associated with the program includes 93.279.
From a funding standpoint, the opportunity is structured as a discretionary grant with an award ceiling of $350,000. The posting and creation dates were May 5, 2016, and the listed closing date for the referenced cycle was September 7, 2018. While the notice includes a field for expected awards, it is not populated in the provided data, so the number of awards for that cycle is not specified here. Overall, the grant is best understood as support for institutions and organizations that want to create or expand research-focused educational pipelines in addiction science for clinicians and clinical researchers, with deliverables centered on skills-building coursework and meaningful, supervised research experiences rather than routine clinical training.
FAQs: NIDA Research Education Program for Clinical Researchers and Clinicians (R25) - PAR-16-224
What is the NIDA Research Education Program for Clinical Researchers and Clinicians (R25)?
It is a National Institutes of Health (NIH) research education grant that uses the R25 mechanism to support structured education activities that build and strengthen the clinical research workforce, with a specific emphasis on substance use and addiction.
What is the funding opportunity number for this program?
The funding opportunity number is PAR-16-224.
Which federal agencies run or sponsor this opportunity?
The program is run through the U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH). It is listed as HHS-NIH11 in the provided information.
What is the main purpose of this grant?
The purpose is to complement and enhance existing training pathways by creating targeted research education experiences that help clinicians and clinician-researchers become stronger consumers and producers of addiction-related research, while staying grounded in real clinical and service settings.
What topic area does the program focus on?
The program focuses on substance use and addiction science. The intent is to strengthen research knowledge and capabilities related to prevention, diagnosis, treatment, and service delivery for substance use disorders.
Is this grant meant to fund general clinical training?
No. A key point is that the program is aimed at research education tied to substance abuse and addiction science, not general clinical training.
Can grant funds be used to pay for clinical instruction unrelated to research?
No. The information provided states the grant cannot be used to pay for clinical instruction that is unrelated to research.
Who is the intended audience for the supported education activities?
The program is designed to expand research knowledge and capabilities for people in clinically focused careers, including current or future clinicians, service providers, and clinical researchers.
What kinds of activities does the program support?
The announcement highlights two main supported activity types: (1) Courses for Skills Development and (2) Research Experiences.
What are "Courses for Skills Development" in this program?
They are organized instruction designed to strengthen research competencies clinicians and clinical researchers need to participate meaningfully in addiction research, such as study design, clinical trial methods, ethical and regulatory issues, data analysis, and implementation or dissemination approaches.
What are "Research Experiences" in this program?
They are hands-on opportunities in research environments where participants learn by doing, often through mentored projects, participation in ongoing studies, or structured research practicums aligned with substance use and addiction topics.
Does the program allow flexibility in how education activities are designed?
Yes. The announcement emphasizes creativity and indicates applicants can propose program models that fit their target audience, as long as the primary focus remains on research education elements (skills-building courses and/or research experiences) tied to substance use and addiction.
What does it mean that this is an NIH R25 mechanism?
Based on the information provided, the R25 mechanism is used to support structured education activities that expand research knowledge and capabilities for clinically focused participants, specifically in substance use and addiction research for this opportunity.
What types of organizations are eligible to apply?
Eligibility is broad and includes many types of domestic organizations, including: state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and certain tribal organizations; public housing authorities and Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status, with certain exclusions noted in the full announcement); for-profit organizations other than small businesses; small businesses; and other entities as allowed under the additional eligibility language in the full announcement.
Is this opportunity limited to universities or academic medical centers?
No. While institutions of higher education are eligible, the eligibility list also includes multiple non-academic entity types such as government entities, nonprofits, for-profits, small businesses, tribal governments and organizations, and certain housing authorities.
Is this a discretionary grant?
Yes. The opportunity is structured as a discretionary grant.
What is the maximum award amount (award ceiling) listed for this opportunity?
The award ceiling listed is $350,000.
How many awards were expected for the referenced cycle?
The provided information shows a field for expected awards, but it is not populated. The number of awards for that cycle is not specified in the data provided here.
What are the key dates shown for this opportunity?
The posting and creation dates are May 5, 2016. The listed closing date for the referenced cycle is September 7, 2018.
What is the CFDA number associated with this program?
The CFDA number associated with the program includes 93.279.
What funding activity categories are associated with this opportunity?
The funding activity category is listed under Education and Health.
What outcomes is this program trying to support?
It aims to develop clinicians and clinician-researchers who can better bridge patient care and research by improving their ability to understand research methods, engage with evidence-based practices, and contribute to studies that advance addiction-related prevention, diagnosis, treatment, and service delivery.
What is the practical focus of the deliverables this grant supports?
The grant is best understood as support for creating or expanding research-focused educational pipelines in addiction science, with deliverables centered on skills-building coursework and meaningful, supervised research experiences rather than routine clinical training.
Does the program encourage participants to remain connected to clinical or service settings?
Yes. The program explicitly encourages designs that build research-relevant skills and exposure while remaining grounded in real clinical and service settings.
Browse more business programs for Education Programs
Browse more opportunities from the same agency: HHS-NIH11
Browse more opportunities from the same category: Education, Health
Next opportunity: DoD Peer Reviewed Medical Clinical Trial Award
Previous opportunity: The Role of Mobile Genetic Elements in Cancer (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 16 224
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 16 224) also looked into and applied for these:
| Funding Opportunity |
|---|
| The Role of Mobile Genetic Elements in Cancer (R01) Apply for PAR 16 227 Funding Number: PAR 16 227 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Metabolic Reprogramming to Improve Immunotherapy (R21) Apply for PAR 16 229 Funding Number: PAR 16 229 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Non-healing Ulcerative Wounds in Aging (R01) Apply for PA 16 230 Funding Number: PA 16 230 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Metabolic Reprogramming to Improve Immunotherapy (R01) Apply for PAR 16 228 Funding Number: PAR 16 228 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites with Enhanced Diversity (U01) Apply for RFA HG 16 011 Funding Number: RFA HG 16 011 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $2,500,000 |
| Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites (U01) Apply for RFA HG 16 010 Funding Number: RFA HG 16 010 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $2,000,000 |
| Neural Regulation of Cancer (R01) Apply for PAR 16 245 Funding Number: PAR 16 245 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Neural Regulation of Cancer (R21) Apply for PAR 16 246 Funding Number: PAR 16 246 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Prescription Drug Abuse (R01) Apply for PA 16 233 Funding Number: PA 16 233 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Gene Fusions in Pediatric Sarcomas (R01) Apply for PA 16 251 Funding Number: PA 16 251 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01) Apply for PAR 16 249 Funding Number: PAR 16 249 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Gene Fusions in Pediatric Sarcomas (R21) Apply for PA 16 252 Funding Number: PA 16 252 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21) Apply for PAR 16 248 Funding Number: PAR 16 248 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Accelerating the Pace of Drug Abuse Research Using Existing Data (R01) Apply for PAR 16 234 Funding Number: PAR 16 234 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $500,000 |
| Building Evidence: Effective Palliative/End of Life Care Interventions (R01) Apply for PAR 16 250 Funding Number: PAR 16 250 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21) Apply for PAR 16 257 Funding Number: PAR 16 257 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Cancer-related Behavioral Research through Integrating Existing Data (R21) Apply for PAR 16 255 Funding Number: PAR 16 255 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Cancer-related Behavioral Research through Integrating Existing Data (R01) Apply for PAR 16 256 Funding Number: PAR 16 256 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Methodology and Measurement in the Behavioral and Social Sciences (R01) Apply for PAR 16 260 Funding Number: PAR 16 260 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) Apply for PA 16 258 Funding Number: PA 16 258 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 16 224", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.